{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:59:14Z","timestamp":1785945554557,"version":"3.56.0"},"reference-count":23,"publisher":"Informa Healthcare","issue":"16","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2015,11,2]]},"DOI":"10.1517\/14656566.2015.1090426","type":"journal-article","created":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T05:44:40Z","timestamp":1442987080000},"page":"2523-2529","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":20,"title":["Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women"],"prefix":"10.1517","volume":"16","author":[{"given":"Ida","family":"Dhanuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","published-online":{"date-parts":[[2015,9,22]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181898cdb"},{"key":"CIT0002","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Fourth Edition. APA, Arlington, VA; 1994"},{"key":"CIT0003","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Fifth Edition. APA, Arlington, VA; 2014","DOI":"10.1176\/appi.books.9780890425596"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.8125tx7c"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2012.02965.x"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2014(04)11"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.1.91"},{"key":"CIT0009","unstructured":"AndroGel\u00ae (testosterone gel) 1% Prescribing Information. AbbVie Inc. Chicago; 2015"},{"key":"CIT0010","unstructured":"Parlodel\u00ae (bromocriptine mesylate) Consumer Medicine Information. Novartis Pharmaceuticals, 2013"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2011.08.027"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2002.tb00219.x"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2010.02032.x"},{"key":"CIT0014","author":"Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee","year":"2015","journal-title":"FDA Briefing Document. NDA 022526 Flibanserin"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12189"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2011.02595.x"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2011.02626.x"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000134"},{"key":"CIT0019","unstructured":"ADDYI (flibanserin) Prescribing Information. Sprout Pharmaceuticals Inc. Raleigh, NC; 2015"},{"key":"CIT0020","author":"Risk Evaluation and Mitigation Strategy (REMS)","year":"2015","journal-title":"NDA 022526 AddyiTM (flibanserin)"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12878"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2012.02850.x"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1080\/713847100"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.13.1441"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.2015.1090426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T22:01:20Z","timestamp":1567202480000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.2015.1090426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,22]]},"references-count":23,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2015,9,11]]},"published-print":{"date-parts":[[2015,11,2]]}},"alternative-id":["10.1517\/14656566.2015.1090426"],"URL":"https:\/\/doi.org\/10.1517\/14656566.2015.1090426","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}